Establishment Labs (ESTA) to Release Quarterly Earnings on Wednesday

Establishment Labs (NASDAQ:ESTA) will likely be releasing its earnings data after the market closes on Wednesday, February 26th. Analysts expect Establishment Labs to post earnings of ($0.64) per share and revenue of $44.45 million for the quarter. Persons interested in registering for the company’s earnings conference call can do so using this link.

Establishment Labs Stock Performance

NASDAQ ESTA opened at $35.38 on Wednesday. The firm has a market cap of $990.64 million, a price-to-earnings ratio of -13.71 and a beta of 1.12. The company has a 50 day moving average of $38.72 and a 200-day moving average of $41.46. The company has a current ratio of 3.62, a quick ratio of 2.29 and a debt-to-equity ratio of 5.94. Establishment Labs has a 1-year low of $28.16 and a 1-year high of $60.12.

Wall Street Analyst Weigh In

Separately, Stephens raised shares of Establishment Labs to a “strong-buy” rating in a report on Monday, December 2nd. One analyst has rated the stock with a hold rating, three have assigned a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Buy” and an average target price of $60.60.

Establishment Labs Company Profile

Establishment Labs Holdings Inc, a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander.